Identification of a robust signature for clinical outcomes and immunotherapy response in gastric cancer: based on N6-methyladenosine related long noncoding RNAs

Abstract Background Gastric cancer (GC) is a globally prevalent cancer, ranking fifth for incidence and fourth for mortality worldwide. The N6-methyladenosine (m6A) related long noncoding RNAs (lncRNAs) were widely investigated in recent studies. Nevertheless, the underlying prognostic implication a...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Tenghui Han, Dong Xu, Jun Zhu, Jipeng Li, Lei Liu, Yanchun Deng
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	BMC 2021-08-01
Edice:	Cancer Cell International
Témata:	m6A modification Gastric cancer Immune checkpoint blockers LncRNA FTO
On-line přístup:	https://doi.org/10.1186/s12935-021-02146-w
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!